ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.76 USD
-4.03%
Market Closed
Updated:
Apr 19, 2024
ADC Therapeutics SA
Total Assets
Last
Value
3-Years CAGR
5-Years CAGR
|
ADC Therapeutics SA
Total Assets Peer Comparison
Comparables:
ACIU
CRSP
BSLN
IDIA
KURN
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Total Assets
$354.8m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Total Assets
CHf182.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Total Assets
$2.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Total Assets
CHf173.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-5%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Total Assets
CHf904.2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Total Assets
CHf71.5m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Total Assets?
Total Assets
354.8m
USD
354.8m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Total Assets amounts to 354.8m USD.
What is ADC Therapeutics SA's Total Assets growth rate?
Total Assets CAGR 5Y
19%
19%
Over the last year, the Total Assets growth was -33%. The average annual Total Assets growth rates for ADC Therapeutics SA have been -12% over the past three years , 19% over the past five years .
You don't have any saved screeners yet
